David Mayer
Partner

has been a private equity investor since joining Golder, Thoma, Cressey, Rauner (GTCR) in 1992. Prior to that he worked at Volpe, Welty & Company, a boutique investment banking firm in San Francisco. Before joining Abingworth in 2008, he was one of five Managing Partners at Thoma Cressey Equity Partners (TCEP) which managed more than $1.75 billion in capital and opened their Boston office in 2004. Investments made during his time at TCEP include: ESP Pharma, Critical Care Systems, Essent Healthcare, Continuing Care RX, Jazz Pharmaceuticals, and Atritech. He has a BSM from Tulane University and earned his MBA at the Kellogg School of Management at Northwestern University. David is based in Boston and his prime responsibility is supporting Abingworth’s efforts in growth equity, which includes growth capital and acquisition financings, growth buyouts and build-ups in healthcare services and life sciences companies.